Log In
BCIQ
Print this Print this
 

dasiglucagon, ZP4207 in multiple-dose pen

Also known as: ZP4207

  Manage Alerts
Collapse Summary General Information
Company Zealand Pharma A/S
DescriptionStable glucagon analog in a liquid dosage form delivered in a multiple-dose pen
Molecular Target Glucagon receptor (GCGR)
Mechanism of ActionGlucagon receptor agonist
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationHypoglycemia
Indication DetailsTreat mild to severe hypoglycemia
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

06/10/2016

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today